Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicifadine in chronic low back pain
NCT00295711Phase 3Completed
- Sponsor
- DOV Pharmaceutical, Inc.
- Start
- Sep 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of bicifadine in chronic low back pain (CLBP) (4 arms), sponsored by DOV Pharmaceutical, Inc. Primary endpoint: Pain Severity Rating (Visual Analog Scale). Started Sep 2004; status: completed.
02
Drugs
bicifadine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00295711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295711.